Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Fmoc-L-Methionine, also known as N-(9-fluorenylmethoxycarbonyl)-L-methionine, is a synthetic derivative of the essential amino acid L-Methionine. It is characterized by the presence of a 9-fluorenylmethoxycarbonyl (Fmoc) protecting group attached to the amino group, which is crucial for its applications in peptide synthesis and other chemical processes. This modification enhances the stability and reactivity of L-Methionine, making it a versatile compound in various industries.

71989-28-1

Post Buying Request

71989-28-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71989-28-1 Usage

Uses

Used in Pharmaceutical Industry:
Fmoc-L-Methionine is used as a building block for the synthesis of peptides and proteins, which are essential components of numerous pharmaceutical products. The Fmoc protecting group allows for the stepwise assembly of peptide chains, facilitating the controlled and efficient production of complex bioactive molecules.
Used in Research and Development:
In the field of research, Fmoc-L-Methionine serves as a valuable tool for studying the structure, function, and interactions of proteins. Its unique properties enable the investigation of protein synthesis, folding, and stability, as well as the development of novel therapeutic agents targeting specific protein pathways.
Used in Food Industry:
Fmoc-L-Methionine can be utilized in the food industry for the production of flavor enhancers and other additives. Its ability to mimic the taste and properties of natural L-Methionine makes it a useful ingredient in the development of new food products and the improvement of existing ones.
Used in Cosmetics Industry:
In the cosmetics industry, Fmoc-L-Methionine may be employed as an ingredient in skincare and haircare products. Its role in protein synthesis and its antioxidant properties can contribute to the development of products that promote skin health and hair growth.
Used in Agricultural Industry:
Fmoc-L-Methionine can also find applications in the agricultural sector, where it may be used to enhance the nutritional value of animal feed or to improve the growth and health of crops. Its role in protein synthesis and its antioxidant properties can contribute to the overall well-being and productivity of plants and animals.

Check Digit Verification of cas no

The CAS Registry Mumber 71989-28-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,9,8 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 71989-28:
(7*7)+(6*1)+(5*9)+(4*8)+(3*9)+(2*2)+(1*8)=171
171 % 10 = 1
So 71989-28-1 is a valid CAS Registry Number.
InChI:InChI=1/C20H21NO4S/c1-26-11-10-18(19(22)23)21-20(24)25-12-17-15-8-4-2-6-13(15)14-7-3-5-9-16(14)17/h2-9,17-18H,10-12H2,1H3,(H,21,24)(H,22,23)/p-1/t18-/m0/s1

71989-28-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (F0296)  N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-methionine  >98.0%(HPLC)(T)

  • 71989-28-1

  • 1g

  • 115.00CNY

  • Detail
  • TCI America

  • (F0296)  N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-methionine  >98.0%(HPLC)(T)

  • 71989-28-1

  • 5g

  • 160.00CNY

  • Detail
  • TCI America

  • (F0296)  N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-methionine  >98.0%(HPLC)(T)

  • 71989-28-1

  • 25g

  • 590.00CNY

  • Detail
  • Alfa Aesar

  • (B21220)  N-Fmoc-L-methionine, 98+%   

  • 71989-28-1

  • 5g

  • 336.0CNY

  • Detail
  • Alfa Aesar

  • (B21220)  N-Fmoc-L-methionine, 98+%   

  • 71989-28-1

  • 25g

  • 1415.0CNY

  • Detail
  • Aldrich

  • (47634)  Fmoc-Met-OH  ≥98.0% (HPLC)

  • 71989-28-1

  • 47634-5G-F

  • 244.53CNY

  • Detail
  • Aldrich

  • (47634)  Fmoc-Met-OH  ≥98.0% (HPLC)

  • 71989-28-1

  • 47634-25G-F

  • 313.56CNY

  • Detail
  • Aldrich

  • (47634)  Fmoc-Met-OH  ≥98.0% (HPLC)

  • 71989-28-1

  • 47634-100G-F

  • 939.51CNY

  • Detail

71989-28-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name FMOC-L-Methionine

1.2 Other means of identification

Product number -
Other names Fmoc-methionine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71989-28-1 SDS

71989-28-1Synthetic route

2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanyl-butyric acid methyl ester
500872-34-4

2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanyl-butyric acid methyl ester

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With aluminium trichloride; N,N-dimethyl-aniline In dichloromethane98%
L-methionine
63-68-3

L-methionine

(9-fluorenyl)methyl pentafluorophenyl carbonate
88744-04-1

(9-fluorenyl)methyl pentafluorophenyl carbonate

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; acetone Ambient temperature;84%
L-methionine
63-68-3

L-methionine

1-[(9-fluorenylmethyloxycarbonyl)]benzotriazole
1131148-55-4

1-[(9-fluorenylmethyloxycarbonyl)]benzotriazole

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With triethylamine In water; acetonitrile at 20℃; for 2h;84%
L-methionine
63-68-3

L-methionine

4-(9-fluorenylmethoxycarbonyloxy) phenyl dimethylsulfonium methylsulfate

4-(9-fluorenylmethoxycarbonyloxy) phenyl dimethylsulfonium methylsulfate

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With triethylamine In water Ambient temperature;80%
L-methionine
63-68-3

L-methionine

(fluorenylmethoxy)carbonyl chloride
28920-43-6

(fluorenylmethoxy)carbonyl chloride

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
Stage #1: L-methionine With chloro-trimethyl-silane In dichloromethane for 1h; Inert atmosphere; Reflux;
Stage #2: (fluorenylmethoxy)carbonyl chloride With N-ethyl-N,N-diisopropylamine In dichloromethane at 5 - 20℃; for 1.5h;
80%
In acetonitrile at 20℃; for 0.25h; pH=9.2; aq. borate buffer;
Stage #1: L-methionine With sodium carbonate In 1,4-dioxane; water Cooling with ice;
Stage #2: (fluorenylmethoxy)carbonyl chloride In 1,4-dioxane; water at 20℃; for 5h;
L-methionine
63-68-3

L-methionine

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With sodium hydrogencarbonate In N,N-dimethyl-formamide at 50℃;78%
Stage #1: L-methionine With N-cyclohexyl-cyclohexanamine In acetone at 20℃;
Stage #2: N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide With sodium carbonate In water; acetonitrile at 0 - 20℃; pH=8;
Stage #3: With potassium hydrogensulfate In water; acetonitrile pH=2 - 3;
61%
With sodium hydrogencarbonate In water; N,N-dimethyl-formamide at 0 - 20℃; for 2h;
C23H29NO4SSi

C23H29NO4SSi

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With methanol In dichloromethane for 0.5h; Ambient temperature; Yield given;
N-Fmoc-L-methionine phenacyl ester

N-Fmoc-L-methionine phenacyl ester

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With magnesium; acetic acid In methanol; N,N-dimethyl-formamide at 20℃; for 75h;
L-methionine
63-68-3

L-methionine

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: CH2Cl2 / 1 h / Heating
2: CH2Cl2 / 72 h / Ambient temperature
3: MeOH / CH2Cl2 / 0.5 h / Ambient temperature
View Scheme
O-(Trimethylsilyl)methionine
5269-64-7

O-(Trimethylsilyl)methionine

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: CH2Cl2 / 72 h / Ambient temperature
2: MeOH / CH2Cl2 / 0.5 h / Ambient temperature
View Scheme
(fluorenylmethoxy)carbonyl chloride
28920-43-6

(fluorenylmethoxy)carbonyl chloride

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 2 h / 10 °C
2: triethylamine / water; acetonitrile / 2 h / 20 °C
View Scheme
picolyl N-Fmoc-L-methioninate
1361400-97-6

picolyl N-Fmoc-L-methioninate

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
With magnesium In methanol at 20℃; for 4h;
(fluorenylmethoxy)carbonyl chloride
28920-43-6

(fluorenylmethoxy)carbonyl chloride

A

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

B

Nα-fluorenyl-9-methoxycarbonyl-D-Met
71989-28-1, 144701-23-5, 112883-40-6

Nα-fluorenyl-9-methoxycarbonyl-D-Met

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium carbonate / water; 1,4-dioxane / Cooling with ice
1.2: 5 h / 20 °C
2.1: trifluoroacetic acid / isopropyl alcohol; hexane / 25 °C / Resolution of racemate
View Scheme
N-Fmoc-methionine
144701-23-5

N-Fmoc-methionine

A

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

B

Nα-fluorenyl-9-methoxycarbonyl-D-Met
71989-28-1, 144701-23-5, 112883-40-6

Nα-fluorenyl-9-methoxycarbonyl-D-Met

Conditions
ConditionsYield
With trifluoroacetic acid In hexane; isopropyl alcohol at 25℃; Reagent/catalyst; Resolution of racemate;
With chiral column based on 3,5-dimethylphenylcarbamoylated β-cyclodextrin combining cinchona alkaloid immobilized on silica gel In methanol; formic acid; triethylamine; acetonitrile at 25℃; Reagent/catalyst; Resolution of racemate; enantioselective reaction;
DL-methionine
59-51-8

DL-methionine

A

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

B

Nα-fluorenyl-9-methoxycarbonyl-D-Met
71989-28-1, 144701-23-5, 112883-40-6

Nα-fluorenyl-9-methoxycarbonyl-D-Met

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium carbonate / water; 1,4-dioxane / Cooling with ice
1.2: 5 h / 20 °C
2.1: trifluoroacetic acid / isopropyl alcohol; hexane / 25 °C / Resolution of racemate
View Scheme
mono-oxidized L-methionine

mono-oxidized L-methionine

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
Stage #1: mono-oxidized L-methionine With chloro-trimethyl-silane In N,N-dimethyl-formamide at 20℃; Pummerer Sulfoxide Rearrangement;
Stage #2: With 1,3-dihydro-imidazole-2-thione In N,N-dimethyl-formamide at 20℃; Solvent; Reagent/catalyst; Pummerer Sulfoxide Rearrangement;
90 %Chromat.
1,3-dihydro-imidazole-2-thione
872-35-5

1,3-dihydro-imidazole-2-thione

mono-oxidized L-methionine

mono-oxidized L-methionine

A

C23H23N3O4S2

C23H23N3O4S2

B

S-(((1H-imidazol-2-yl)thio)methyl)-N-(((9H-fluoren-9-yl)methoxy)carbonyl)-L-homocysteine

S-(((1H-imidazol-2-yl)thio)methyl)-N-(((9H-fluoren-9-yl)methoxy)carbonyl)-L-homocysteine

C

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Conditions
ConditionsYield
Stage #1: mono-oxidized L-methionine With chloro-trimethyl-silane In ethyl acetate at 20℃; Pummerer Sulfoxide Rearrangement;
Stage #2: 1,3-dihydro-imidazole-2-thione In ethyl acetate at 20℃; Solvent; Reagent/catalyst; Pummerer Sulfoxide Rearrangement;
A n/a
B n/a
C 8 %Chromat.
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(9H-fluoren-9-yl)methyl (S)-(1-amino-4-(methylthio)-1-oxobutan-2-yl)carbamate
314732-61-1

(9H-fluoren-9-yl)methyl (S)-(1-amino-4-(methylthio)-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With chloroformic acid ethyl ester; triethylamine In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: With ammonium chloride In tetrahydrofuran; water at 0℃; for 0.5h;
100%
With pyridine; di-tert-butyl dicarbonate; ammonium bicarbonate In 1,4-dioxane; N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;91%
With ammonium bicarbonate; N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline In acetonitrile at 20℃; for 15h;86%
Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

Fmoc-Pro-OH
71989-31-6

Fmoc-Pro-OH

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

trifluoroacetic acid
76-05-1

trifluoroacetic acid

(4S)-4-{[(9-fluorenylmethyloxy)carbonyl]amino}-5-({2-[([(2-{[(9H-fluorenylmethoxy)carbonyl]amino}ethyl)amino]{[(4-methylphenyl)-sulfonyl]imino}methyl)amino]ethyl}amino)-5-oxopentanoic acid

(4S)-4-{[(9-fluorenylmethyloxy)carbonyl]amino}-5-({2-[([(2-{[(9H-fluorenylmethoxy)carbonyl]amino}ethyl)amino]{[(4-methylphenyl)-sulfonyl]imino}methyl)amino]ethyl}amino)-5-oxopentanoic acid

C49H83N13O10S3*C2HF3O2

C49H83N13O10S3*C2HF3O2

Conditions
ConditionsYield
Multistep reaction.;100%
C42H37ClNO6Pol

C42H37ClNO6Pol

C29H31NO5

C29H31NO5

N-Cbz-L-Phe
1161-13-3

N-Cbz-L-Phe

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine
35661-39-3

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine

O-benzyl-N-Fmoc-L-serine
122889-11-6, 83792-48-7

O-benzyl-N-Fmoc-L-serine

Fmoc-Pro-OH
71989-31-6

Fmoc-Pro-OH

Fmoc-Ser(tBu)-OH
71989-33-8

Fmoc-Ser(tBu)-OH

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Nα-FMOC-Nω-L-tosylarginine
139090-50-9, 83792-47-6

Nα-FMOC-Nω-L-tosylarginine

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-threonine
146346-82-9

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-threonine

N-alpha-(9-fluorenylmethyloxycarbonyl)-L-aspartic acid beta-allyl ester
146982-24-3

N-alpha-(9-fluorenylmethyloxycarbonyl)-L-aspartic acid beta-allyl ester

Z-Phe-Ala-Thr(TBS)-Met-Arg(Tos)-Tyr(Pen)-Pro-Ser(tBu)-Asp(OAll)-Ser(Bzl)-Asp(OtBu)-OH
1240360-55-7

Z-Phe-Ala-Thr(TBS)-Met-Arg(Tos)-Tyr(Pen)-Pro-Ser(tBu)-Asp(OAll)-Ser(Bzl)-Asp(OtBu)-OH

Conditions
ConditionsYield
Stage #1: C42H37ClNO6Pol With morpholine Automated synthesizer; solid phase reaction;
Stage #2: O-benzyl-N-Fmoc-L-serine With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; 6-chloro-1-hydroxybenzotriazole In 1-methyl-pyrrolidin-2-one Automated synthesizer; solid phase reaction;
Stage #3: C29H31NO5; N-Cbz-L-Phe; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine; Fmoc-Pro-OH; Fmoc-Ser(tBu)-OH; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine; Nα-FMOC-Nω-L-tosylarginine; N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-threonine; N-alpha-(9-fluorenylmethyloxycarbonyl)-L-aspartic acid beta-allyl ester Further stages;
100%
N-(fluoren-9-ylmethoxycarbonyl)glycine
29022-11-5

N-(fluoren-9-ylmethoxycarbonyl)glycine

N-Fmoc L-Phe
35661-40-6

N-Fmoc L-Phe

Fmoc-Glu(OtBu)-OH
71989-18-9

Fmoc-Glu(OtBu)-OH

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

N3-L-Gly-L-Phe-L-Glu(OtBu)-L-Met-L-Glu(OtBu)-L-Met-OH

N3-L-Gly-L-Phe-L-Glu(OtBu)-L-Met-L-Glu(OtBu)-L-Met-OH

Conditions
ConditionsYield
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With N-ethyl-N,N-diisopropylamine In methanol; dichloromethane; N,N-dimethyl-formamide for 1.33333h; Inert atmosphere;
Stage #2: With piperidine In N,N-dimethyl-formamide for 0.333333h; Inert atmosphere;
Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; N-Fmoc L-Phe; Fmoc-Glu(OtBu)-OH; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine Further stages;
99%
N-Fmoc L-Phe
35661-40-6

N-Fmoc L-Phe

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Fmoc-L-Phe-L-Met-L-Phe-L-Met-OH

Fmoc-L-Phe-L-Met-L-Phe-L-Met-OH

Conditions
ConditionsYield
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With N-ethyl-N,N-diisopropylamine In methanol; dichloromethane; N,N-dimethyl-formamide for 1.33333h; Inert atmosphere;
Stage #2: With piperidine In N,N-dimethyl-formamide for 0.333333h; Inert atmosphere;
Stage #3: N-Fmoc L-Phe; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine Further stages;
99%
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With N-ethyl-N,N-diisopropylamine In dichloromethane for 1.08333h; Inert atmosphere;
Stage #2: With piperidine In N,N-dimethyl-formamide for 0.166667h; Inert atmosphere;
Stage #3: N-Fmoc L-Phe; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine Further stages;
99%
N-(fluoren-9-ylmethoxycarbonyl)glycine
29022-11-5

N-(fluoren-9-ylmethoxycarbonyl)glycine

N-Fmoc L-Phe
35661-40-6

N-Fmoc L-Phe

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Nα-(9-fluorenylmethoxycarbonyl)-L-glutamic acid α-allyl ester
144120-54-7

Nα-(9-fluorenylmethoxycarbonyl)-L-glutamic acid α-allyl ester

cyclo-[L-Met-Gly-L-Met-L-Phe-L-Phe-L-Glu]

cyclo-[L-Met-Gly-L-Met-L-Phe-L-Phe-L-Glu]

Conditions
ConditionsYield
Stage #1: Nα-(9-fluorenylmethoxycarbonyl)-L-glutamic acid α-allyl ester With N-ethyl-N,N-diisopropylamine In dichloromethane for 0.916667h;
Stage #2: With piperidine In N,N-dimethyl-formamide for 0.333333h;
Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; N-Fmoc L-Phe; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine Further stages;
99%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

1-methyl-1-phenylethyl 2,2,2-trichloroacetimidoate
147221-33-8

1-methyl-1-phenylethyl 2,2,2-trichloroacetimidoate

(S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanyl-butyric acid 1-methyl-1-phenyl-ethyl ester

(S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanyl-butyric acid 1-methyl-1-phenyl-ethyl ester

Conditions
ConditionsYield
In dichloromethane98%
In dichloromethane at 20℃; for 16h;95%
N-(2,2-diethoxyethyl)-3-methylbutan-1-amine
103647-81-0

N-(2,2-diethoxyethyl)-3-methylbutan-1-amine

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(S)-(9H-fluoren-9-yl)methyl 1-((2,2-diethoxyethyl)(isopentyl)amino)-4-(methylthio)-1-oxobutan-2-ylcarbamate

(S)-(9H-fluoren-9-yl)methyl 1-((2,2-diethoxyethyl)(isopentyl)amino)-4-(methylthio)-1-oxobutan-2-ylcarbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; Cooling with ice;98%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

3-hydroxy-3,4-dihydrobenzotriazine-4-one
28230-32-2

3-hydroxy-3,4-dihydrobenzotriazine-4-one

Fmoc-Met-ODhbt
119767-83-8

Fmoc-Met-ODhbt

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at -15 - 4℃;95%
With thionyl chloride In dichloromethane Heating;92%
tert-Butyl 2,2,2-trichloroacetimidate
98946-18-0

tert-Butyl 2,2,2-trichloroacetimidate

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanyl-butyric acid tert-butyl ester

(S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanyl-butyric acid tert-butyl ester

Conditions
ConditionsYield
In dichloromethane Heating;95%
(4-iodomethylphenoxy)acetic acid 2-oxo-2-phenylethyl ester
913987-81-2

(4-iodomethylphenoxy)acetic acid 2-oxo-2-phenylethyl ester

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

4-(Fmoc-methionyloxymethyl)phenoxyacetic acid 2-phenacyl ester
913987-86-7

4-(Fmoc-methionyloxymethyl)phenoxyacetic acid 2-phenacyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine at 0℃;95%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

L-methionine
63-68-3

L-methionine

Conditions
ConditionsYield
With sodium azide In N,N-dimethyl-formamide at 50℃; for 16h;95%
formaldehyd
50-00-0

formaldehyd

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(4S)-3-(9-fluorenylmethyloxycarbonyl)-4-<2-(methylthio)ethyl>-5-oxooxazolidine
84000-02-2

(4S)-3-(9-fluorenylmethyloxycarbonyl)-4-<2-(methylthio)ethyl>-5-oxooxazolidine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 2h; Reflux;94%
With toluene-4-sulfonic acid In toluene for 0.5h; Heating;88%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

α-bromoacetophenone
70-11-1

α-bromoacetophenone

N-Fmoc-L-methionine phenacyl ester

N-Fmoc-L-methionine phenacyl ester

Conditions
ConditionsYield
With triethylamine In ethyl acetate; N,N-dimethyl-formamide at 0℃; for 18h;94%
(E)-1α,25-dihydroxy-2-(1′-amino-3′,6′,9′-trioxadodecan-12′-ylidene)-19-norvitamin D3

(E)-1α,25-dihydroxy-2-(1′-amino-3′,6′,9′-trioxadodecan-12′-ylidene)-19-norvitamin D3

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(E)-1α,25-dihydroxy-2-[1′-(9′’H-fluoren-9′’-yl)-5′-[2′’’-(methylthio)ethyl]-3′,6′-dioxo-2′,10′,13′,16′-tetraoxa-4′,7′-diazanonadecan-19′-ylidene]-19-norvitamin D3

(E)-1α,25-dihydroxy-2-[1′-(9′’H-fluoren-9′’-yl)-5′-[2′’’-(methylthio)ethyl]-3′,6′-dioxo-2′,10′,13′,16′-tetraoxa-4′,7′-diazanonadecan-19′-ylidene]-19-norvitamin D3

Conditions
ConditionsYield
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 1h; Inert atmosphere;
Stage #2: (E)-1α,25-dihydroxy-2-(1′-amino-3′,6′,9′-trioxadodecan-12′-ylidene)-19-norvitamin D3 In dichloromethane Inert atmosphere;
94%
2,3,4,5,6-pentafluorophenol
771-61-9

2,3,4,5,6-pentafluorophenol

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

N-α-Fmoc-L-methionine pentafluorophenyl ester
86060-94-8

N-α-Fmoc-L-methionine pentafluorophenyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In ethyl acetate 0 deg C, 1 h; r.t., 1 h;93%
With dicyclohexyl-carbodiimide In ethyl acetate at 0℃; for 2h; Yield given;
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

pentafluorophenyl 4-nitrobenzenesulfonate
244633-31-6

pentafluorophenyl 4-nitrobenzenesulfonate

N-α-Fmoc-L-methionine pentafluorophenyl ester
86060-94-8

N-α-Fmoc-L-methionine pentafluorophenyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Esterification;93%
methyl 2-aminoisobutyrate hydrochloride
15028-41-8

methyl 2-aminoisobutyrate hydrochloride

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Fmoc-L-Met-Aib-OMe
1124322-46-8

Fmoc-L-Met-Aib-OMe

Conditions
ConditionsYield
With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;93%
2-docosyloxy-4-methoxybenzyl alcohol
1313025-22-7

2-docosyloxy-4-methoxybenzyl alcohol

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

C50H73NO6S
1313025-44-3

C50H73NO6S

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform at 20℃; for 1h; Cooling with ice;93%
L-leucine benzyl ester p-toluenesulfonate
1738-77-8

L-leucine benzyl ester p-toluenesulfonate

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Fmoc-Met-Leu-OBzl ester

Fmoc-Met-Leu-OBzl ester

Conditions
ConditionsYield
Stage #1: L-leucine benzyl ester p-toluenesulfonate With triethylamine In dichloromethane at 20℃; for 0.5h;
Stage #2: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 20℃;
93%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(9H-fluoren-9-yl)methyl (S)-(1-fluoro-4-(methylthio)-1-oxobutan-2-yl)carbamate
130859-02-8

(9H-fluoren-9-yl)methyl (S)-(1-fluoro-4-(methylthio)-1-oxobutan-2-yl)carbamate

Conditions
ConditionsYield
With tetramethylammonium trifluoromethanethiolate In dichloromethane at 20℃; for 0.0833333h;92%
With pyridine; trifluoro-[1,3,5]triazine In dichloromethane for 4h; Ambient temperature;80%
With pyridine; trifluoro-[1,3,5]triazine In dichloromethane at 20℃;74%
With pyridine; trifluoro-[1,3,5]triazine In dichloromethane for 2h;72%
L-leucine benzyl ester hydrochloride
2462-35-3

L-leucine benzyl ester hydrochloride

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Fmoc-Met-Leu-OBzl ester

Fmoc-Met-Leu-OBzl ester

Conditions
ConditionsYield
With C36H24B4N2O3 In toluene at 80℃; for 48h; Inert atmosphere; Molecular sieve;92%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

(S)-2-((S)-2-Amino-4-methyl-pentanoylamino)-3-phenyl-propionic acid (benzhydryl-carbamoyl)-methyl ester; compound with trifluoro-acetic acid
119706-37-5

(S)-2-((S)-2-Amino-4-methyl-pentanoylamino)-3-phenyl-propionic acid (benzhydryl-carbamoyl)-methyl ester; compound with trifluoro-acetic acid

Fmoc-Met-Leu-Phe-OBg
119706-25-1

Fmoc-Met-Leu-Phe-OBg

Conditions
ConditionsYield
With 4-methyl-morpholine; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide for 0.5h; Ambient temperature;91%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Ala-Ile-Pro-O-t-Bu

Ala-Ile-Pro-O-t-Bu

N-Fmoc-Met-Ala-Ile-Pro-t-Bu

N-Fmoc-Met-Ala-Ile-Pro-t-Bu

Conditions
ConditionsYield
With diethyl cyanophosphonate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; Addition; Peptide-bond formation;91%
1,2,3-Benzotriazole
95-14-7

1,2,3-Benzotriazole

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

9H-fluoren-9-ylmethyl N-[(1S)-1-(1H-1,2,3-benzotriazol-1-ylcarbonyl)-3-(methylsulfanyl)propyl]carbamate
850232-62-1

9H-fluoren-9-ylmethyl N-[(1S)-1-(1H-1,2,3-benzotriazol-1-ylcarbonyl)-3-(methylsulfanyl)propyl]carbamate

Conditions
ConditionsYield
Stage #1: 1,2,3-Benzotriazole With thionyl chloride In tetrahydrofuran at 25℃; for 0.5h; Inert atmosphere;
Stage #2: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine In tetrahydrofuran at 20℃; for 2h; Inert atmosphere;
91%
Stage #1: 1,2,3-Benzotriazole With thionyl chloride In tetrahydrofuran at 35 - 40℃; for 0.333333h;
Stage #2: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine In tetrahydrofuran at 25℃; for 2h;
87%
Stage #1: 1,2,3-Benzotriazole With thionyl chloride In tetrahydrofuran at 40 - 50℃; for 0.333333h;
Stage #2: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine In tetrahydrofuran at 20℃; for 2h;
87%
With thionyl chloride In tetrahydrofuran at 20℃; for 2h;
curcumin
147556-16-9

curcumin

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

((1E,3Z,6E)-3-hydroxy-5-oxohepta-1,3,6-triene-1,7-diyl)bis(2-methoxy-4,1-phenylene) (2S,2'S)-bis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(methylthio)butanoate)

((1E,3Z,6E)-3-hydroxy-5-oxohepta-1,3,6-triene-1,7-diyl)bis(2-methoxy-4,1-phenylene) (2S,2'S)-bis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(methylthio)butanoate)

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at -5 - 0℃;91%
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Fmoc-methioninechloride
103321-54-6

Fmoc-methioninechloride

Conditions
ConditionsYield
With thionyl chloride; N,N-dimethyl-formamide In dichloromethane for 1h; Ambient temperature;90.3%
With thionyl chloride In dichloromethane for 24h; Ambient temperature;90%
With pyridine; thionyl chloride In dichloromethane Heating;
N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Fmoc-Met-N(CH3)-OCH3

Fmoc-Met-N(CH3)-OCH3

Conditions
ConditionsYield
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; 1,8-diazabicyclo[5.4.0]undec-7-ene In ethyl acetate; acetonitrile at 0℃; for 0.166667h;
Stage #2: N,O-dimethylhydroxylamine*hydrochloride With triethylamine In ethyl acetate; acetonitrile at 0℃; for 0.5h;
90%
Stage #1: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With trichloroacetonitrile; triphenylphosphine In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
Stage #2: N,O-dimethylhydroxylamine*hydrochloride With triethylamine In tetrahydrofuran at 20℃; for 2h; Inert atmosphere;
78%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine
Stage #1: N,O-dimethylhydroxylamine*hydrochloride; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate In acetonitrile at 0℃; Inert atmosphere;
Stage #2: With N-ethyl-N,N-diisopropylamine In acetonitrile at 0 - 20℃; Inert atmosphere;
Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

N-Fmoc L-Phe
35661-40-6

N-Fmoc L-Phe

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine
71989-28-1

N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

NH2-RMLRF-OH

NH2-RMLRF-OH

Conditions
ConditionsYield
Stage #1: N-Fmoc L-Phe With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.666667h;
Stage #2: With N-ethyl-N,N-diisopropylamine In methanol; dichloromethane at 20℃; for 0.166667h;
Stage #3: Fmoc-Leu-OH; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages;
90%

71989-28-1Relevant articles and documents

Novel chiral stationary phases based on 3,5-dimethyl phenylcarbamoylated β-cyclodextrin combining cinchona alkaloid moiety

Zhu, Lunan,Zhu, Junchen,Sun, Xiaotong,Wu, Yaling,Wang, Huiying,Cheng, Lingping,Shen, Jiawei,Ke, Yanxiong

, p. 1080 - 1090 (2020/05/25)

Novel chiral selectors based on 3,5-dimethyl phenylcarbamoylated β-cyclodextrin connecting quinine (QN) or quinidine (QD) moiety were synthesized and immobilized on silica gel. Their chromatographic performances were investigated by comparing to the 3,5-dimethyl phenylcarbamoylated β-cyclodextrin (β-CD) chiral stationary phase (CSP) and 9-O-(tert-butylcarbamoyl)-QN-based CSP (QN-AX). Fmoc-protected amino acids, chiral drug cloprostenol (which has been successfully employed in veterinary medicine), and neutral chiral analytes were evaluated on CSPs, and the results showed that the novel CSPs characterized as both enantioseparation capabilities of CD-based CSP and QN/QD-based CSPs have broader application range than β-CD-based CSP or QN/QD-based CSPs. It was found that QN/QD moieties play a dominant role in the overall enantioseparation process of Fmoc-amino acids accompanied by the synergistic effect of β-CD moiety, which lead to the different enantioseparation of β-CD-QN-based CSP and β-CD-QD-based CSP. Furthermore, new CSPs retain extraordinary enantioseparation of cyclodextrin-based CSP for some neutral analytes on normal phase and even exhibit better enantioseparation than the corresponding β-CD-based CSP for certain samples.

Repurposing the Pummerer Rearrangement: Determination of Methionine Sulfoxides in Peptides

Woodroofe, Carolyn C.,Ivanic, Joseph,Monti, Sarah,Levine, Rodney L.,Swenson, Rolf E.

, p. 508 - 516 (2019/11/13)

The reversible oxidation of methionine residues in proteins has emerged as a biologically important post-translational modification. However, detection and quantitation of methionine sulfoxide in proteins is difficult. Our aim is to develop a method for specifically derivatizing methionine sulfoxide residues. We report a Pummerer rearrangement of methionine sulfoxide treated sequentially with trimethylsilyl chloride and then 2-mercaptoimidazole or pyridine-2-thiol to produce a dithioacetal product. This derivative is stable to standard mass spectrometry conditions, and its formation identified oxidized methionine residues. The scope and requirements of dithioacetal formation are reported for methionine sulfoxide and model substrates. The reaction intermediates have been investigated by computational techniques and by 13C NMR spectroscopy. These provide evidence for an α-chlorinated intermediate. The derivatization allows for detection and quantitation of methionine sulfoxide in proteins by mass spectrometry and potentially by immunochemical methods.

Diethyl Selenodiglycolate: An Eco-Friendly Synthetic Antioxidant with Potential Application to Inflammatory Disorders

Archilha, Marcos V. L. R.,Giroldo, Lilian,Kuznetsov, Aleksey E.,Meotti, Flávia C.,Pinatto-Botelho, Marcos F.,da Silva, Railmara P.,dos Santos, Alcindo A.

, p. 1239 - 1248 (2020/10/14)

This study describes a single step, high yield and purity, ecofriendly and scalable procedure to prepare a selenium derivative (diethyl selenodiglycolate). Diethyl selenodiglycolate rapidly reduces hypochlorous acid (HOCl, second-order rate constant of 7 × 107 M?1 s?1) to generate its corresponding selenoxide. In activated HL-60 cells, diethyl selenodiglycolate selectively reacted with HOCl (half maximal inhibitory concentration (IC50) = 23.07 μM) but not with superoxide anion radical or hydrogen peroxide without any cytotoxicity. These results show that this synthetically simple selenide reacts in a very efficient and specific way with the harmful pro-oxidant HOCl being a promising compound to be applied in oxidative inflammatory-related conditions.

Determination of Chemical and Enantiomeric Purity of α-Amino Acids and their Methyl Esters as N-Fluorenylmethoxycarbonyl Derivatives Using Amylose-derived Chiral Stationary Phases

Islam, Md. Fokhrul,Adhikari, Suraj,Paik, Man-Jeong,Lee, Wonjae

, p. 332 - 338 (2019/04/13)

Liquid chromatographic enantiomer separation and simultaneous determination of chemical and enantiomeric purity of α-amino acids and their methyl esters as N-fluorenylmethoxycarbonyl (FMOC) derivatives was performed on three covalently bonded type chiral stationary phases (CSPs) derived from amylose derivatives. The enantiomer separation of α-amino acid esters as N-FMOC derivatives was better than that of the corresponding acids, especially for CSP 1 and 2. Chemical impurities as the corresponding racemic acids present in several commercially available racemic amino acid methyl esters were observed to be 0.49–17.50%. Enantiomeric impurities of several commercially available L-amino acid methyl esters were found to be 0.03–0.58%, whereas chemical impurities as the corresponding racemic acids present in the same analytes were found to be 0.13–13.62%. This developed analytical method will be useful for the determination of chemical and enantiomeric purity of α-amino acids and/or esters as N-FMOC derivatives using amylose-derived CSPs.

Preparation method of methionine derivative corrosion inhibitor

-

Paragraph 0019; 0020, (2016/10/31)

The invention discloses a preparation method of a methionine derivative corrosion inhibitor. The method comprises the following steps: synthesis of Fmoc-methionine: adding methionine and Fmoc-OSu into a DMF (N,N-dimethylformamide) solvent to react, and adding NaHCO3 to remove the solvent and residual amine compounds, thereby obtaining the product, wherein the yield is 78%; synthesis of Fmoc-methionine acyl chloride: adding the Fmoc-methionine into 25ml of CH2Cl2, and refluxing to react for 4 hours; and synthesis of Fmoc-methionine amide: after the acyl-chlorination reaction, directly adding into an equal mole of octadecylamine CH2Cl2 solution to obtain a yellow solid, and purifying the product by a chromatographic column separation process, wherein the eluting solution is composed of dichloromethane and methanol in a volume ratio of 20:1. According to the preparation method, the Fmoc- protective group is connected to the methionine molecule by amidation, and the adsorption site formed by the pi-electron-containing benzene ring enhances the adsorptivity of the corrosion inhibitor molecule. The hydrophobic long chain is connected to the methionine molecule to resist the attack of water molecules, so that a protective film is formed on the steel surface, thereby achieving the goal of corrosion inhibition.

Caged xanthones: Potent inhibitors of global predominant MRSA USA300

Chaiyakunvat, Pongkorn,Anantachoke, Natthinee,Reutrakul, Vichai,Jiarpinitnun, Chutima

supporting information, p. 2980 - 2983 (2016/06/13)

Total of 22 caged xanthones were subjected to susceptibility testing of global epidemic MRSA USA300. Natural morellic acid showed the strongest potency (MIC of 12.5 μM). However, its potent toxicity diminishes MRSA therapeutic potential. We synthetically modified natural morellic acid to yield 13 derivatives (3a-3m). Synthetically modified 3b retained strong potency in MRSA growth inhibition, yet the toxicity was 20-fold less than natural morellic acid, permitting the possibility of using caged xanthones for MRSA therapeutic.

A mild method for the cleavage of the 4-picolyloxy group with magnesium under neutral conditions

Zhu, Jianwei,Miao, Wenjun,Bao, Lingling,Ji, Tao,Tang, Guo,Xu, Pengxiang,Zhao, Yufen

supporting information; experimental part, p. 142 - 144 (2012/02/04)

A mild and efficient method for the selective hydrolysis of 4-picolyl esters with magnesium in methanol or water in the presence of other esters and sensitive protecting groups is described. 4-Picolyl aryl ethers and thioethers are also smoothly deprotected to give the corresponding phenols and thiophenols. Georg Thieme Verlag Stuttgart. New York.

Liquid-chromatography quantitative analysis of 20 amino acids after derivatization with FMOC-CI and its application to different origin Radix isatidis

Zhou, Wei,Zhang, Xiao-Yan,Duan, Geng-Li

experimental part, p. 509 - 515 (2012/01/04)

We developed a simple, rapid and reliable method for determination of 20 common amino acids based on derivatization with 9-fluorenylmethyl chloroformate (FMOC-CI) and RP-LC/UV, this method was first introduced into quantitative analysis of amino acids. The amino groups of amino acids were trapped with FMOC-CI to form amino acid-FMOC-Cl adducts which can be suitable for LC-UV. Chromatographic separation was performed on a C18 column with a mobile phase gradient consisting of acetonitrile and sodium acetate solution. This method was shown to be sensitive for 20 common amino acids. In the intra-day precisions assay, the range of RSDs was 3.21-7.67% with accuracies of 92.34-102.51%; for the inter-day precisions assay, the range of RSDs was 5.82-9.19% with accuracies of 90.25-100.63%. The results also indicated that solutions of amino acids-FMOC-Cl can be kept at room temperature for at least 24 h without showing significant losses in the quantified values. The validated method was successfully applied to the determination of major four kinds of amino acids in R. isatidis samples (Arg, Pro, Met and Val). The total content of amino acids in different origin R. isatidis was 13.32-19.16 mg/g. The differences between R. isatidis samples were large using HCA.

Benzotriazole reagents for the syntheses of Fmoc-, Boc-, and Alloc-protected amino acids

Ibrahim, Tarek S.,Tala, Srinivasa R.,El-Feky, Said A.,Abdel-Samii, Zakaria K.,Katritzky, Alan R.

, p. 2013 - 2016 (2011/10/08)

Stable Fmoc-, Boc-, and Alloc-benzotriazoles react with various amino acids including unprotected serine and glutamic acid, in the presence of triethylamine at 20° as reagents to introduce -amino protecting groups to afford Fmoc-, Boc-, and Alloc-protected amino acids (77-94%) free of dipeptide and tripeptide impurities. Fmoc-, and Alloc-Gly-Gly-OH dipeptides were prepared in 90% yields by N-acylation of glycylglycine with Fmoc- and Alloc-benzotriazoles in the presence of triethylamine. Synthesized N-protected amino acids were greater than 99% pure, analyzed by HPLC. Georg Thieme Verlag Stuttgart - New York.

Efficient procedure for the preparation of oligomer-free N-fmoc amino acids

Nowshuddin, Shaik,Rao,Reddy, A. Ram

experimental part, p. 2022 - 2031 (2009/11/30)

A two-step method is presented for the peptide-free, high-purity, and high-yield synthesis of N-Fmoc amino acids. The first step involves the preparation of stable dicyclohexylammonium-amino acid ionic adduct in acetone. Subsequently, the ionic adducts, on reaction with Fmoc-Nosu under mild alkaline conditions, give dipeptide-free N-Fmoc amino acids. The positive charge of the dicyclohexylammonium counterion in the ionic salt has a longer radius, moderating the nucleophilicity of the carboxylate ion of the amino acid and preventing by-products by arresting the formation of mixed anhydrides, the precursors of oligopeptide impurities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 71989-28-1